๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial

โœ Scribed by Douglas Feltner; Cheryl Hill; William Lenderking; Valerie Williams; Robert Morlock


Book ID
113750520
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
173 KB
Volume
43
Category
Article
ISSN
0022-3956

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Ritanserin in the treatment of generaliz
โœ E. A. Pangalila-Ratu Langi; A. A. I. Jansen ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 381 KB ๐Ÿ‘ 2 views

In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)